CellnTec Advanced Cell Systems

CELLnTEC is a private, revenue-generating tools and platform company providing essential reagents for advanced cell culture. It has established itself as a key supplier of precision media and 3D model systems for epithelial research, serving academic, pharmaceutical, and translational research markets. The company's strategy focuses on developing chemically defined, higher-certified media to support the transition from research to clinical-grade cell therapy manufacturing. Recent activities, such as participation in the NEOLIVER consortium for bioprinted livers, indicate an expansion into complex tissue engineering and closer collaboration with therapeutic developers.

Precision, chemically-defined, xeno-free cell culture media and 3D model systems based on advanced epithelial cell biology.

CELLnTEC competes in the niche of specialized epithelial cell culture media against larger players like Thermo Fisher Scientific and Merck KGaA (MilliporeSigma), as well as other focused providers such as PromoCell and ATCC. Its differentiation lies in its deep focus on epithelial biology, chemically-defined formulations, and products specifically designed for seamless 2D-to-3D workflow transition.